CDXS_OUT_1 [2025-03-24 10:59:07 -0400] 1875 Bytes | 554 tokens | Cum: 554 tkns (6.93% of 8k)
==========================================================================

Turbo, you got one job - predict the hottest stocks of the day -- before everyone else does! Ha! So today we're looking at Codexis (CDXS) which is at 3.1065 up from 2.55. So, I pulled together a bunch of data for you to look over real fast. It's still early, 10:59:06 AM on Mon Mar 24, 2025 -0400. So, what's the verdict? You're the expert!

Here's the first list of news for Codexis:

C1 - Today 07:00AM - Codexis Announces First Revenue-Generating Contract for ECO Synthesis Manufacturing Services
C2 - Mar-07-25 04:05PM - Codexis Announces New Employment Inducement Grants
C3 - Feb-28-25 11:02AM - Q4 2024 Codexis Inc Earnings Call
C4 - Feb-28-25 11:02AM 02:36AM - Codexis Inc (CDXS) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Revenue Growth ...
C5 - Feb-27-25 06:35PM - Codexis (CDXS) Reports Q4 Loss, Misses Revenue Estimates
C6 - Feb-27-25 06:35PM 05:36PM - Codexis: Q4 Earnings Snapshot
C7 - Feb-27-25 06:35PM 04:05PM - Codexis Reports Fourth Quarter and Fiscal Year 2024 Financial Results
C8 - Feb-18-25 04:05PM - Codexis to Participate in TD Cowen 45th Annual Health Care Conference

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Codexis (CDXS)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

CDXS_OUT_3 [2025-03-24 10:59:10 -0400] 1042 Bytes | 282 tokens | Cum: 838 tkns (10.47% of 8k)
==========================================================================

Showing C1 (chunk 1 of 7): C1:
**Codexis Announces First Revenue-Generating Contract for ECO Synthesis Manufacturing Services**
Date: Today 07:00AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/03/24/3047710/24825/en/Codexis-Announces-First-Revenue-Generating-Contract-for-ECO-Synthesis-Manufacturing-Services.html

March 24, 2025 07:00 ET| Source:Codexis, Inc.Codexis, Inc.Redwood City, CA

Represents first project to enter the ECO Synthesis™ Innovation Lab

Core enzymes for ECO Synthesis™ technology have transitioned from research into development and scale-up as the first step in securing the raw materials supply chain

REDWOOD CITY, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced its first revenue-generating contract to manufacture siRNA materia

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

CDXS_OUT_5 [2025-03-24 10:59:12 -0400] 925 Bytes | 268 tokens | Cum: 1108 tkns (13.85% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-24T11:23:15Z - Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services...
A2 - 2025-03-24T11:16:56Z - Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services | Taiw...
A3 - 2025-03-13T11:51:41Z - FY2025 EPS Estimates for Codexis Cut by Cantor Fitzgerald...
A4 - 2025-03-13T10:07:44Z - Codexis, Inc. (NASDAQ:CDXS) Stock Holdings Lifted by Telemark Asset Management LLC...
A5 - 2025-03-07T21:06:52Z - Codexis Announces New Employment Inducement Grants...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

CDXS_OUT_7 [2025-03-24 10:59:13 -0400] 1044 Bytes | 274 tokens | Cum: 1384 tkns (17.30% of 8k)
==========================================================================

Showing A1 (chunk 1 of 7): A1:
**Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services**Date: 2025-03-24Source: {'uri': 'manilatimes.net', 'dataType': 'news', 'title': 'The Manila times'}URL: https://www.manilatimes.net/2025/03/24/tmt-newswire/globenewswire/codexis-announces-first-revenue-generating-contract-for-eco-synthesis-manufacturing-services/2078636Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders

Represents first project to enter the ECO Synthesis™ Innovation Lab

Core enzymes for ECO Synthesis™ technology have transitioned from research into development and scale-up as the first step in securing the raw materials supply chain

REDWOOD CITY, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, t

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

CDXS_OUT_9 [2025-03-24 10:59:15 -0400] 930 Bytes | 301 tokens | Cum: 1687 tkns (21.09% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2025-02-20T15:00:00Z - Specialty Enzymes Market to Expand at 7.5% CAGR, Reaching USD 10.7 Billion by 2032 | SNS Insider
B2 - 2024-12-04T18:00:00Z - Global Artificial Sweeteners Market to Observe Growth at a CAGR of ~4% by 2030 | DelveInsight
B3 - 2024-07-01T20:05:00Z - Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets
B4 - 2024-05-22T20:25:00Z - Codexis to Participate in Jefferies Global Healthcare Conference
B5 - 2024-05-20T20:05:00Z - Codexis to Participate in TD Cowen 2nd Annual Sustainability Week
B6 - 2024-05-14T10:00:00Z - Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CDXS_OUT_11 [2025-03-24 10:59:21 -0400] 766 Bytes | 225 tokens | Cum: 1914 tkns (23.93% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Specialty Enzymes Market to Expand at 7.5% CAGR, Reaching USD 10.7 Billion by 2032 | SNS Insider**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/02/20/3029807/0/en/Specialty-Enzymes-Market-to-Expand-at-7-5-CAGR-Reaching-USD-10-7-Billion-by-2032-SNS-Insider.htmlThe Specialty Enzymes market is growing rapidly due to increasing applications in food, beverages, and pharmaceuticals. Advancements in science and increasing consumer knowledge of the benefits of health are key driving factors. The market is expected to reach USD 10.7 Billion by 2032, growing at a CAGR of 7.5%.

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

CDXS_OUT_13 [2025-03-24 10:59:22 -0400] 786 Bytes | 200 tokens | Cum: 2185 tkns (27.31% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S5 - 2025-02-27 10-K ITEM 7. MGT DISC & ANALYSIS OF

FIN COND & RESULTS OF OPER

The following management's discussion and analysis of our financial condition and results of operations should be read in conjunction with our audited CONS financial statemen...

S6 - 2025-02-27 8-K Item2.02 Results of Oper and Fin Cond.

On February 27, 2025, Codexis, Inc. announced its financial results for the quarter and year ended December 31, 2024. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CDXS_OUT_15 [2025-03-24 10:59:24 -0400] 1038 Bytes | 220 tokens | Cum: 2407 tkns (30.09% of 8k)
==========================================================================

Showing S5 (chunk 1 of 6): S5:
ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following management's discussion and analysis of our financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and the related notes thereto included elsewhere in this Annual Report on Form 10-K. This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). These statements include, but are not limited to, expectations regarding our strategy, business plans, financial performance and developments relating to our industry. These statements are often identified by the use of words such as may, will, expect, believe, anticipate, intend, could, should, estimate, or continue, and similar expressions or variation

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

CDXS_OUT_17 [2025-03-24 10:59:37 -0400] 6038 Bytes | 1836 tokens | Cum: 4245 tkns (53.06% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+-----------------------+-----------------------+-------------------------+------------------------+-------------------------+
| Volume: 907,772 | SMA50: -19.74% | Market Cap: 256.80M | Option/Short: Yes / Yes | Sales past 5Y: 4.02% | Sales Surprise: -21.71% |
+---------------------+-----------------------+-----------------------+-------------------------+------------------------+-------------------------+
| Avg Volume: 777.40K | SMA200: -15.44% | Shs Outstand: 81.85M | Short Float: 3.76% | Employees: 188 | EPS Surprise: -258.13% |
+---------------------+-----------------------+-----------------------+-------------------------+------------------------+-------------------------+
| Rel Volume: 5.13 | Perf Week: 6.16% | Shs Float: 80.57M | Short Ratio: 3.90 | Debt/Eq: 0.89 | P/E: - |
+---------------------+-----------------------+-----------------------+-------------------------+------------------------+-------------------------+
| RSI (14): 47.80 | Perf Month: -25.84% | Inst Own: 78.32% | Short Interest: 3.03M | Sales Y/Y TTM: -15.39% | Earnings: Feb 27 AMC |
+---------------------+-----------------------+-----------------------+-------------------------+------------------------+-------------------------+
| ATR (14): 0.28 | Perf Quarter: -40.27% | Insider Own: 2.74% | Beta: 2.38 | ROE: -85.03% | |
+---------------------+-----------------------+-----------------------+-------------------------+------------------------+-------------------------+
| SMA20: 5.43% | Index: RUT | Insider Trans: 45.99% | Sales Q/Q: -19.20% | ROI: -52.64% | |
+---------------------+-----------------------+-----------------------+-------------------------+------------------------+-------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

Inside Trans: CODEXIS, INC. (CDXS) by Opaleye Management Inc. (Unknown Title) on 2025-03-13
- Common Stock, par value $0.001 per share: 85000 shares at $2.543 (I)

Inside Trans: CODEXIS, INC. (CDXS) by Opaleye Management Inc. (Unknown Title) on 2025-03-06
- Common Stock, par value $0.001 per share: 100000 shares at $2.6135 (I)

Inside Trans: CODEXIS, INC. (CDXS) by Opaleye Management Inc. (Unknown Title) on 2025-03-04
- Common Stock, par value $0.001 per share: 55000 shares at $2.6436 (I)
- Common Stock, par value $0.001 per share: 10000 shares at $2.6875 (I)

Inside Trans: CODEXIS, INC. (CDXS) by Opaleye Management Inc. (Unknown Title) on 2025-02-28
- Common Stock, par value $0.001 per share: 147649 shares at $2.988 (I)
- Common Stock, par value $0.001 per share: 47351 shares at $2.8123 (I)

Inside Trans: CODEXIS, INC. (CDXS) by Opaleye Management Inc. (Unknown Title) on 2025-02-10
- Common Stock, par value $0.001 per share: 22500 shares at $4.1844 (I)
- Common Stock, par value $0.001 per share: 12500 shares at $4.112 (I)
- Common Stock, par value $0.001 per share: 15000 shares at $3.9955 (I)

Inside Trans: CODEXIS, INC. (CDXS) by DILLY STEPHEN GEORGE (See Remarks) on 2025-02-05
- Common Stock: 88750 shares at $0 (D)
- Stock Option (Right to Buy): 532500 shares at $0 (D)

Inside Trans: CODEXIS, INC. (CDXS) by Erbez Georgia (Chief Financial Officer) on 2025-02-05
- Common Stock: 26875 shares at $0 (D)
- Stock Option (Right to Buy): 161250 shares at $0 (D)

Inside Trans: CODEXIS, INC. (CDXS) by MOORE ALISON (Chief Technical Officer) on 2025-02-05
- Common Stock: 26875 shares at $0 (D)
- Stock Option (Right to Buy): 161250 shares at $0 (D)

[Company Financial Summary]
[Company Details]
Name: Codexis, Inc.
Market Cap: 211235143.04999998
Shares Outstanding: 82837311
Sector: INDUSTRIAL ORGANIC CHEMICALS

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 64446000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -62092000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 3.065
Average Volume: 1137470.76
30-Day High: 4.16
30-Day Low: 2.53

[Detailed Financials: Q3 2024]
- Total Assets: $148,183,000.0
- Total Liabilities: $74,783,000.0
- Total Equity: $73,400,000.0
- Current Assets: $112,902,000.0
- Current Liabilities: $35,129,000.0

[Income Statement: Q3 2024]
- Revenue: $12,833,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.29

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $18,854,000.0

[Detailed Financials: Q2 2024]
- Total Assets: $132,006,000.0
- Total Liabilities: $70,559,000.0
- Total Equity: $61,447,000.0
- Current Assets: $91,398,000.0
- Current Liabilities: $30,539,000.0

[Income Statement: Q2 2024]
- Revenue: $7,979,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.32

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-39,452,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

CDXS_OUT_19 [2025-03-24 10:59:39 -0400] 676 Bytes | 167 tokens | Cum: 4601 tkns (57.51% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

CDXS_IN_21 [2025-03-24 10:59:40 -0400] 126 Bytes | 29 tokens | Cum: 4658 tkns (58.23% of 8k)
==========================================================================

====================================
[2025-03-24 07:59:40] # Analysis Completed
Elapsed Time: 34.85 seconds